ITPR2 Blocking Peptide for STJ501515 peptide (STJ504273)

SKU:
STJ504273-250

£289.50
Shipping:
Free Shipping
Current Stock:
Applications: Immunodepletion/Immunocompetition
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: ITPR2 Blocking Peptide for STJ501515 is synthetically produced from the 100-150 sequence and is suitable for use in western blot applications.
Formulation: Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: Itpr2
Gene ID: 81678
Uniprot ID: ITPR2_RAT
Immunogen Region: 100-150
Specificity: This blocking peptide is recommended for use in combination with ITPR2 antibody, STJ501515
Immunogen: Synthetic peptide taken within amino acid region 100-150 on rat Inosital 1, 4, 5-triphosphate receptor type 2 protein.
Post Translational Modifications Phosphorylation by cAMP-dependent PKA on Ser-937 increases calcium release.
Function Receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. This release is regulated by cAMP both dependently and independently of PKA.
Peptide Name Inositol 1 -4 -5-Trisphosphate Receptor Type 2
Ip3 Receptor Isoform 2
Ip3r 2
Insp3r2
Type 2 Inositol 1 -4 -5-Trisphosphate Receptor
Type 2 Insp3 Receptor
Database Links Reactome: R-RNO-114508
Reactome: -RNO-139853
Reactome: -RNO-381676
Reactome: -RNO-5578775
Reactome: -RNO-983695
Cellular Localisation Endoplasmic Reticulum Membrane
Multi-Pass Membrane Protein
Alternative Peptide Names Inositol 1 -4 -5-Trisphosphate Receptor Type 2 protein
Ip3 Receptor Isoform 2 protein
Ip3r 2 protein
Insp3r2 protein
Type 2 Inositol 1 -4 -5-Trisphosphate Receptor protein
Type 2 Insp3 Receptor protein
Itpr2 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance